Literature DB >> 2664629

Angle-closure glaucoma complicating ciliochoroidal detachment.

S Fourman1.   

Abstract

Acute angle-closure glaucoma complicating ciliochoroidal detachment developed in eight eyes of six patients. The clinical presentation was uniform: extremely shallow central anterior chamber depth, flat peripheral anterior chamber, closed angle, and elevated intraocular pressure (IOP). There were three patients with uveal effusion syndrome, two with posterior scleritis, and one with an arteriovenous malformation. Cycloplegia, along with aqueous suppressants and corticosteroids, successfully resolved the acute glaucoma in all eyes. This rare, secondary glaucoma must be differentiated from primary angle-closure glaucoma, because the treatment is markedly different. Although primary angle-closure glaucoma is treated with miotics and peripheral iridectomy, such therapy may worsen the glaucoma in eyes with angle-closure glaucoma due to a ciliochoridal detachment.

Entities:  

Mesh:

Year:  1989        PMID: 2664629     DOI: 10.1016/s0161-6420(89)32850-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

Review 1.  Primary acute angle-closure glaucoma complicating ciliochoroidal detachment: report of four cases and review of the literature.

Authors:  Yan Zhang; Chao Wang; Li Liu; Yingqing Lei; Yue He; Ling Yu
Journal:  Int Ophthalmol       Date:  2017-11-23       Impact factor: 2.031

2.  Ciliochoroidal effusion syndrome associated with posterior scleritis.

Authors:  Naohiro Ikeda; Tomohiro Ikeda; Chika Nomura; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

3.  Glaucoma: Adverse event on use of topiramate in alcohol de-addiction.

Authors:  Keshava Pai; Pooja Rajashekaran
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

4.  A rare case of acute angle closure due to spontaneous suprachoroidal haemorrhage secondary to loss of anti-coagulation control: a case report.

Authors:  Ibrahim Masri; Jonathan M Smith; Nicholas K Wride; Saurabh Ghosh
Journal:  BMC Ophthalmol       Date:  2018-09-14       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.